期刊文献+

S100A8和S100A9与肾细胞癌关系的研究进展

The Relationship between S100A8 and S100A9 and Renal Cell Carcinoma
下载PDF
导出
摘要 肾细胞癌(renal cell carcinoma, RCC)是泌尿系统中最常见的肿瘤类型之一,在泌尿系统中,发病率居于首位的是前列腺癌,其次是膀胱癌,RCC紧随其后,位居第三。RCC早期发现经治疗后治愈率高,中晚期行肾切除术,术后效果不佳,药物治疗效果亦不显著。S100A8和S100A9隶属于S100蛋白家族,二者可以形成结构稳定的异二聚体——钙卫蛋白,近年来研究显示,S100A8和S100A9与RCC之间具有密不可分的联系。本文对S100A8和S100A9与RCC之间的关系及应用前景进行综述,以期为RCC的诊断、治疗及靶向药物的研发提供更多的思路和方向。 Renal cell carcinoma (RCC) is one of the most common types of tumor in the urinary system. In the urinary system, the incidence of prostate cancer is the highest, bladder cancer was second, followed by RCC in third place. If RCC is not found in early stage, the curative rate is high. When RCC develops to middle and late stage, nephrectomy will be performed. S100A8 and S100A9 are members of the S100 protein family, which can form calprotectin, a stable heterodimer. Recent studies have shown that S100A8 and S100A9 are closely related to RCC. This article reviews the relationship between S100A8 and S100A9 and RCC and their application prospect, in order to provide more ideas and directions for the diagnosis, treatment and research and development of targeted drugs for RCC.
出处 《临床医学进展》 2023年第7期10707-10712,共6页 Advances in Clinical Medicine
  • 相关文献

参考文献10

二级参考文献27

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部